Versor Investments’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Versor Investments’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,556	Closed	-$972K	–	981
2022 Q2	$972K	Sell	13,556 -413	-3%	-$30.2K	0.04%	261
2022 Q1	$1.13M	Buy	13,969 +11,469	+459%	+$970K	0.04%	105
2021 Q4	$257K	Sell	2,500 -1,400	-36%	-$134K	0.01%	445
2021 Q3	$341K	Buy	+3,900	New	+$353K	0.01%	349
2020 Q4	–	Sell	-8,313	Closed	-$442K	–	290
2020 Q3	$442K	Buy	+8,313	New	+$495K	0.04%	168
2020 Q1	–	Sell	-26,084	Closed	-$1.55M	–	362
2019 Q4	$1.55M	Buy	26,084 +4,900	+23%	+$263K	0.08%	87
2019 Q3	$1.13M	Buy	21,184 +8,500	+67%	+$436K	0.08%	126
2019 Q2	$648K	Sell	12,684 -6,907	-35%	-$322K	0.04%	196
2019 Q1	$1.01M	Buy	+19,591	New	+$950K	0.1%	109

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Versor Investments's SYNH Position: Q3 2022 in Review

Versor Investments sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 13,556 shares — an estimated $972K sold.

Versor Investments first reported a position in SYNH in Q1 2019 and held it in 9 quarters. The position peaked at $1.55M in Q4 2019. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Versor Investments reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Versor Investments sold 13,556 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $972K.
Versor Investments first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2019 and held it in 9 quarters.
Versor Investments's Syneos Health, Inc. Class A Common Stock position peaked at $1.55M in Q4 2019.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Versor Investments's 13F filing for Q3 2022, filed 25 Oct 2022.